跳至主要内容
临床试验/IRCT20180120038450N4
IRCT20180120038450N4已完成3 期

Design, fabrication and evaluation of physical and chemical properties and evaluation of the clinical effect of formulation of targeted cerebral drug delivery system through the nose containing Sumatriptan in acute migraine attacks

Kermanshah University of Medical Sciences0 个研究点目标入组 73 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
73

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Patients with 2 to 8 migraine attacks per month
  • History of more than one year with migraine(with aura or without aura)

排除标准

  • History of high blood pressure
  • History of myocardial infarction
  • History of stroke
  • Allergy to sumatriptan
  • History of coronary artery disease
  • History of congenital heart disease
  • Cardiovascular disease
  • Pulmonary disease
  • Cardiac arrhythmias
  • Cerebrovascular disease

研究者

相似试验